Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.4 EUR | +0.48% | +0.96% | -4.22% |
02/04 | Fine Foods narrows loss in 2023; up 22 percent in revenue | AN |
29/03 | Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.22% | 220M | A- | ||
+8.20% | 7.78B | D+ | ||
+0.34% | 7.38B | C- | ||
+10.20% | 6.52B | - | ||
-8.10% | 3.67B | D | ||
-13.13% | 3.44B | B- | ||
-14.57% | 1.17B | - | - | |
+8.34% | 934M | - | ||
-42.27% | 879M | B+ | ||
-18.90% | 836M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FF Stock
- Ratings Fine Foods & Pharmaceuticals N.T.M. S.p.A.